Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 5 studies | 38% ± 9% | |
epithelial cell | 4 studies | 26% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 84% | 19473.18 | 303 / 359 | 49% | 111.28 | 140 / 286 |
bladder | 100% | 4675.57 | 21 / 21 | 31% | 141.27 | 157 / 504 |
liver | 52% | 1843.85 | 118 / 226 | 75% | 914.83 | 304 / 406 |
esophagus | 42% | 5373.31 | 606 / 1445 | 77% | 446.94 | 140 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 42.67 | 1 / 1 |
intestine | 54% | 3321.62 | 517 / 966 | 43% | 62.19 | 225 / 527 |
tonsil | 0% | 0 | 0 / 0 | 71% | 148.19 | 32 / 45 |
pancreas | 7% | 22.79 | 22 / 328 | 58% | 88.64 | 104 / 178 |
adrenal gland | 64% | 404.14 | 164 / 258 | 1% | 0.60 | 3 / 230 |
kidney | 51% | 806.96 | 45 / 89 | 14% | 134.39 | 128 / 901 |
muscle | 61% | 253.46 | 489 / 803 | 0% | 0 | 0 / 0 |
skin | 55% | 378.50 | 995 / 1809 | 5% | 5.47 | 24 / 472 |
lung | 3% | 30.59 | 20 / 578 | 48% | 405.35 | 560 / 1155 |
uterus | 4% | 180.28 | 6 / 170 | 42% | 154.40 | 192 / 459 |
thymus | 10% | 29.57 | 66 / 653 | 5% | 10.13 | 28 / 605 |
prostate | 13% | 89.81 | 32 / 245 | 0% | 0 | 0 / 502 |
blood vessel | 8% | 23.83 | 112 / 1335 | 0% | 0 | 0 / 0 |
breast | 3% | 16.72 | 12 / 459 | 5% | 6.45 | 59 / 1118 |
ovary | 3% | 6.59 | 5 / 180 | 1% | 0.72 | 6 / 430 |
adipose | 4% | 16.11 | 48 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 12.56 | 9 / 929 | 0% | 0 | 0 / 0 |
heart | 1% | 1.85 | 6 / 861 | 0% | 0 | 0 / 0 |
spleen | 0% | 1.03 | 1 / 241 | 0% | 0 | 0 / 0 |
brain | 0% | 0.10 | 1 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016488 | Biological process | farnesol catabolic process |
GO_0044597 | Biological process | daunorubicin metabolic process |
GO_0044598 | Biological process | doxorubicin metabolic process |
GO_0001523 | Biological process | retinoid metabolic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0110095 | Biological process | cellular detoxification of aldehyde |
GO_0005576 | Cellular component | extracellular region |
GO_0005739 | Cellular component | mitochondrion |
GO_0005764 | Cellular component | lysosome |
GO_0005829 | Cellular component | cytosol |
GO_0047655 | Molecular function | allyl-alcohol dehydrogenase activity |
GO_0047718 | Molecular function | indanol dehydrogenase activity |
GO_0004032 | Molecular function | aldose reductase (NADPH) activity |
GO_0004033 | Molecular function | aldo-keto reductase (NADPH) activity |
GO_0001758 | Molecular function | retinal dehydrogenase activity |
GO_0052650 | Molecular function | all-trans-retinol dehydrogenase (NADP+) activity |
GO_0008106 | Molecular function | alcohol dehydrogenase (NADP+) activity |
GO_0045550 | Molecular function | geranylgeranyl reductase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | AKR1B10 |
Protein name | Aldo-keto reductase family 1 member B10 (EC 1.1.1.300) (EC 1.1.1.54) (ARL-1) (Aldose reductase-like) (Aldose reductase-related protein) (ARP) (hARP) (Small intestine reductase) (SI reductase) |
Synonyms | AKR1B11 |
Description | FUNCTION: Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols . Displays strong enzymatic activity toward all-trans-retinal, 9-cis-retinal, and 13-cis-retinal . Plays a critical role in detoxifying dietary and lipid-derived unsaturated carbonyls, such as crotonaldehyde, 4-hydroxynonenal, trans-2-hexenal, trans-2,4-hexadienal and their glutathione-conjugates carbonyls (GS-carbonyls) . Displays no reductase activity towards glucose . . |
Accessions | O60218 ENST00000359579.5 |